CINECA IRIS Institutional Research Information System

ROCCATELLO, Dario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.961
EU - Europa 31.625
AS - Asia 27.456
SA - Sud America 6.862
AF - Africa 901
OC - Oceania 637
Continente sconosciuto - Info sul continente non disponibili 68
Totale 105.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.697
CN - Cina 9.654
IT - Italia 8.799
SG - Singapore 6.656
BR - Brasile 3.416
FR - Francia 3.147
JP - Giappone 2.966
DE - Germania 2.815
ES - Italia 2.759
IE - Irlanda 2.066
GB - Regno Unito 2.001
MX - Messico 1.926
FI - Finlandia 1.664
SE - Svezia 1.630
KR - Corea 1.419
VN - Vietnam 1.384
UA - Ucraina 1.277
IN - India 1.193
CA - Canada 1.066
CO - Colombia 1.048
AR - Argentina 1.042
PL - Polonia 822
TR - Turchia 715
NL - Olanda 674
HK - Hong Kong 619
RU - Federazione Russa 585
AU - Australia 583
TW - Taiwan 465
CL - Cile 454
ID - Indonesia 438
CH - Svizzera 437
GR - Grecia 437
AT - Austria 392
BE - Belgio 369
TH - Thailandia 352
PT - Portogallo 346
PE - Perù 317
RO - Romania 297
IL - Israele 284
EC - Ecuador 257
SA - Arabia Saudita 193
DK - Danimarca 172
EG - Egitto 154
MA - Marocco 140
VE - Venezuela 136
TN - Tunisia 128
HU - Ungheria 125
BD - Bangladesh 122
CZ - Repubblica Ceca 122
IR - Iran 116
IQ - Iraq 111
ZA - Sudafrica 110
NO - Norvegia 109
RS - Serbia 109
PH - Filippine 99
PK - Pakistan 96
DZ - Algeria 90
MY - Malesia 87
SI - Slovenia 87
HR - Croazia 86
UY - Uruguay 82
PY - Paraguay 58
BG - Bulgaria 57
CR - Costa Rica 57
EU - Europa 55
AE - Emirati Arabi Uniti 54
UZ - Uzbekistan 54
NZ - Nuova Zelanda 50
BO - Bolivia 45
KE - Kenya 43
PS - Palestinian Territory 43
RE - Reunion 40
DO - Repubblica Dominicana 36
NP - Nepal 35
PA - Panama 34
SK - Slovacchia (Repubblica Slovacca) 32
GT - Guatemala 31
OM - Oman 30
BY - Bielorussia 29
MU - Mauritius 29
LB - Libano 28
CY - Cipro 26
LT - Lituania 25
EE - Estonia 24
JO - Giordania 24
NI - Nicaragua 24
KZ - Kazakistan 23
LV - Lettonia 23
KW - Kuwait 22
MT - Malta 22
NG - Nigeria 22
QA - Qatar 22
AZ - Azerbaigian 20
SN - Senegal 20
ET - Etiopia 18
MD - Moldavia 18
SV - El Salvador 17
AL - Albania 16
BA - Bosnia-Erzegovina 16
HN - Honduras 16
Totale 105.180
Salva come PNG Salva come JPEG
Città #
Singapore 3.453
Beijing 3.327
Chandler 2.053
Dublin 1.983
Santa Clara 1.952
Redwood City 1.898
Houston 1.546
Fairfield 1.545
Ann Arbor 1.342
Ashburn 1.273
Wilmington 932
Torino 914
Jacksonville 885
Villeurbanne 826
Woodbridge 808
Milan 771
Tokyo 768
Helsinki 734
Seattle 678
Medford 664
Dearborn 657
Turin 647
Shanghai 638
Princeton 609
Columbus 584
Cambridge 535
Los Angeles 509
Warsaw 497
Guangzhou 491
São Paulo 489
Seoul 481
Rome 427
Madrid 422
Hefei 414
Bogotá 413
New York 409
Pisa 400
Hong Kong 364
Ho Chi Minh City 363
Paris 363
San Jose 363
Munich 355
Nyköping 353
Buffalo 351
Barcelona 350
Dallas 338
Santiago 335
Buenos Aires 319
The Dalles 310
Nanjing 290
Boston 289
Hangzhou 279
Dong Ket 277
Hanoi 263
Jakarta 256
Medellín 238
Chicago 237
Mexico City 233
Lima 224
Taipei 217
Vienna 214
Chengdu 213
London 210
Fremont 190
Mexico 181
Toronto 181
Istanbul 175
Wuhan 174
Zhengzhou 170
Athens 168
Bangkok 167
Bengaluru 166
Osaka 161
Boardman 158
Sesto San Giovanni 152
Bologna 151
Verona 151
Florence 149
Frankfurt am Main 141
Changsha 133
San Diego 133
Lauterbourg 129
Jinan 128
Guadalajara 126
Rio de Janeiro 123
Valencia 122
Sydney 121
Rochester 120
Quito 115
Berlin 113
Ankara 108
Nuremberg 106
Redondo Beach 106
Brussels 105
Norwalk 103
Ottawa 102
Belo Horizonte 100
Padova 99
Washington 98
Hebei 97
Totale 49.600
Salva come PNG Salva come JPEG
Nome #
Cryoglobulinaemia 7.362
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances 3.960
GAPSS: the Global Anti-Phospholipid Syndrome Score. 2.419
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2.203
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature 1.651
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. 1.569
Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review 1.426
Renal involvement in antiphospholipid syndrome. 1.299
Acute renal infarction: a single center experience 1.226
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents 1.152
Acute kidney injury associated with glomerular diseases 1.152
IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine. 1.135
Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. 1.011
IgG4-related nephropathy 971
Antiphospholipid Syndrome and the Kidney 962
Radiotherapy in patients with connective tissue diseases 919
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment 846
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. 813
Dealing with stuck hemodialysis catheter: state of the art and tips for the nephrologist. 794
[Extracorporeal therapy in sepsis] 761
The global anti-phospholipid syndrome score in primary APS. 675
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome 675
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein) 666
Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence 665
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. 652
Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review 620
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. 619
Catastrophic antiphospholipid syndrome (CAPS). 609
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 606
Pregnancy outcomes in mixed connective tissue disease: a multicentre study 604
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 587
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 585
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. 564
Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials 563
Rheumatoid arthritis: Biological therapy other than anti-TNF 558
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 556
Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review 537
Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome 515
Clinical utility of the global anti-phospholipid syndrome score for risk stratification: A pooled analysis 506
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 504
Living With and Treating Rare Diseases: Experiences of Patients and Professional Health Care Providers 499
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 480
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 471
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 471
Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. 456
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab 447
Anticorpi anti-GM1 ed anti-solfatidi nelle vasculiti sistemiche primitive e secondarie 442
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 438
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 419
Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases. 414
Radiotherapy in patients with HIV: current issues and review of the literature 398
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 394
Nemo syndrome (incontinentia pigmenti) and systemic lupus erythematosus: a new disease association. 387
Treatment of antiphospholipid syndrome 384
Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target? 383
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. 368
Venous Window Needle Guide for deep vessels and difficult arteriovenous fistula cannulation 363
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies 354
The risk of ischaemic stroke in primary APS patients: a prospective study 353
The role of nail-videocapillaroscopy in early diagnosis of scleroderma 350
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 334
Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. 323
Upcoming biological therapies in systemic lupus erythematosus. 320
The dilemma of treating hepatitis C virus-associated cryoglobulinemia 319
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 318
Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study) 318
"How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis 296
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome 294
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets 293
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning. 291
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 289
Fagocitosi monocitaria frusta di crioglobuline in pazienti con nefrite crioglobulinemica 288
A randomized, controlled, trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 284
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes. 281
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection 280
COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome 277
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 275
How I treat patients with systemic sclerosis in clinical practice 273
Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome. 259
Rituximab in cryoglobulinemic peripheral neuropathy 252
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 242
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. 241
The Case | the young philosopher with multiple sclerosis and proteinuria 237
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 235
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis 231
Antiphospholipid syndrome and relapsing polychondritis: an unusual association. 230
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS 230
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score 227
Trasporto e smaltimento degli immunocomplessi circolanti nelle glomerulonefriti umane 226
Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome. 226
Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort. 223
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 223
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 222
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 217
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss 216
Lab-on-a-chip: Emerging analytical platforms for immune-mediated diseases. 215
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 209
Novel diagnostic approaches and cost-benefit balance of treatment of immune-mediated and rare disease in the era of biologic drugs: lessons from the 15th Turin Congress on Immune Pathology and Orphan Disease. 207
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases. 205
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 202
Totale 64.096
Salva come PNG Salva come JPEG
Categoria #
all - tutte 255.583
article - articoli 0
book - libri 0
conference - conferenze 33.209
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 288.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.255 0 0 0 0 0 0 958 728 1.231 1.099 962 1.277
2021/202210.825 748 766 819 932 938 819 823 817 782 672 1.134 1.575
2022/202312.031 1.083 763 521 840 975 2.344 1.189 992 1.152 599 818 755
2023/20249.351 993 1.028 726 777 851 679 704 770 207 686 803 1.127
2024/202516.404 606 972 879 1.536 3.077 1.187 808 1.136 1.686 1.204 1.169 2.144
2025/202613.886 1.848 1.530 1.706 3.223 2.363 1.750 1.466 0 0 0 0 0
Totale 108.315